[1] |
乐伟波, 梁少珊, 邓康平, 等.1 126例中国汉族成人IgA肾病患者的长期预后及危险因素分析[J].肾脏病与透析肾移植杂志, 2011, 20(2):101-108.Le WB, Liang SS, Deng KP, et al. Long-term renal survival and related risk factors of patients with IgA nephropathy: results from a cohort of 1 126 cases in a Chinese adult population[J]. Chin J Nephrol Dial Transplant, 2011, 20(2):101-108.
|
[2] |
沈霞红, 梁少姗, 乐伟波, 等. IgA肾病患者肾组织病变的变化与治疗及预后的关系[J].肾脏病与透析肾移植杂志, 2013, 22(5):401-408. http://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201305001.htmShen XH, Liang SS, Le WB, et al. Clinicopathologic features and treatment response in IgA nephropathy[J]. Chin J Nephrol Dial Transplant, 2013, 22(5):401-408. http://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201305001.htm
|
[3] |
Working Group of the International IgA nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults[J]. Kidney Int, 2010, 77(10):921-927. doi: 10.1038/ki.2010.43
|
[4] |
Han SS, Huh W, Park SK, et al. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy[J]. Transpl Int, 2010, 23(2):169-175. doi: 10.1111/tri.2009.23.issue-2
|
[5] |
Bulut IK, Mir S, Sozeri B, et al. Outcome results in children with IgA nephropathy: a single center experience[J]. Int J Nephrol Renovasc Dis, 2012, 5:23-28. http://core.ac.uk/display/27365227
|
[6] |
姜飞, 俞东容, 蔡丽丽, 等. IgA肾病预后危险因素研究进展[J].中国中西医结合肾病杂志, 2014, 15(11):1024-1026. http://www.cnki.com.cn/Article/CJFDTOTAL-JXSB201411041.htmJiang F, Yu DR, Cai LL, et al. Research progress on the prognostic risk factors of IgA nephropathy [J]. Chin J Integr Tradit West Nephrol, 2014, 15(11):1024-1026. http://www.cnki.com.cn/Article/CJFDTOTAL-JXSB201411041.htm
|
[7] |
Han SS, Huh W, Park SK, et al. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy[J]. Transpl Int, 2010, 23(2):169-175. doi: 10.1111/tri.2009.23.issue-2
|
[8] |
鲁琳.肾移植后IgA肾病复发的研究进展[J].国际泌尿系统杂志, 2010, 30(5):681-684. http://www.cnki.com.cn/Article/CJFDTOTAL-JXSB200704024.htmLu L. The development of the research of recurrent IgA nephropathy after renal transplantation[J]. Int J Urol Nephrol, 2010, 30(5):681-684. http://www.cnki.com.cn/Article/CJFDTOTAL-JXSB200704024.htm
|
[9] |
方明, 林洪丽, 谢华, 等.促纤溶治疗对IgA肾病患者肾脏保护的回顾性队列研究[J].实用医学杂志, 2014, 30(9):1405-1407. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201409019.htmFang M, Lin HL, Xie H, et al. Fibrinolytic therapy on renal protection in IgA nephropathy patients:a retrospective cohort study[J]. J Pract Med, 2014, 30(9):1405-1407. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201409019.htm
|
[10] |
郭君其, 凌志杰, 王科, 等.移植肾肾病复发和新发患者的临床病理分析[J].临床泌尿外科杂志, 2011, 26(1):28-31. http://www.cnki.com.cn/Article/CJFDTOTAL-LCMW201101014.htmGuo JQ, Ling ZJ, Wang K, et al. The analyses of patients with recurrent glomerulonephritis and de novo glomerulonephritis posttransplantation[J]. J Clin Urol, 2011, 26(1):28-31. http://www.cnki.com.cn/Article/CJFDTOTAL-LCMW201101014.htm
|
[11] |
Floege J, Gröne HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition[J]. Nephrol Dial Transplant, 2013, 28(5):1070-1073. doi: 10.1093/ndt/gft077
|
[12] |
Matsukura H, Igarashi N, Kazama T, et al. Concurrent occurrence of juvenile reactive arthritis and IgA nephropathy[J].Clin Nephrol, 2014, 81(5):379-380. doi: 10.5414/CN108200
|
[13] |
周姗姗, 李剑文, 梁鸣, 等.548例肾脏疾病患者临床及病理分析[J].热带医学杂志, 2014, 14(6):767-770, 776. http://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201406026.htmZhou SS, Li JW, Liang M, et al. Clinical and pathological analysis of 548 cases with chronic kidney disease[J]. J Trop Med, 2014, 14(6):767-770, 776. http://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201406026.htm
|
[14] |
Buron F, Hadj-Aissa A, Dubourg L, et al. Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas[J]. Transplantation, 2011, 92(9):1005-1011. http://www.medscape.com/medline/abstract/22031008
|
[15] |
Solez K, Colvin RB, Racusen LC, et al. Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy('CAN')[J]. Am J Transplant, 2007, 7(3):518-526. doi: 10.1111/ajt.2007.7.issue-3
|
[16] |
Wang Y, Ichimaru N, Kyo M, et al. Beneficial effects of tonsillectomy for mesangial immunoglobulin A (IgA) deposition and clinical outcome in five kidney transplant patients with recurrent IgA nephropathy: case report[J]. Transplant Proc, 2014, 46(2):607-609. doi: 10.1016/j.transproceed.2013.11.066
|
[17] |
Von Visger JR, Gunay Y, Andreoni KA, et al. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression[J]. Clin Transplant, 2014, 28(8):845-854. doi: 10.1111/ctr.2014.28.issue-8
|
[18] |
Chhabra D, Skaro AI, Leventhal JR, et al. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus[J]. Clin J Am Soc Nephrol, 2012, 7(3):504-512. doi: 10.2215/CJN.06940711
|
[19] |
Morozumi K, Takeda A, Otsuka Y, et al. Recurrent glomerular disease after kidney transplantation: an update of selected areas and the impact of protocol biopsy[J]. Nephrology, 2014, 19(Suppl 3):6-10. http://www.bioportfolio.com/resources/pmarticle/1007371/Recurrent-glomerular-disease-after-kidney-transplantation-An-update-of-selected-areas-and.html
|
[20] |
Koshino K, Ushigome H, Sakai K, et al. Outcome of tonsillectomy for recurrent IgA nephropathy after kidney transplantation[J]. Clin Transplant, 2013, 27(Suppl 26):22-28. http://www.medscape.com/medline/abstract/24299232
|
[21] |
Berthelot L, Robert T, Vuiblet V, et al. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes[J]. Kidney Int, 2015, 88(4):815-822. doi: 10.1038/ki.2015.158
|
[22] |
Edström Halling S, Söderberg MP, Berg UB. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)[J].Nephrol Dial Transplant, 2012, 27(2):715-722. doi: 10.1093/ndt/gfr339
|
[23] |
Magistroni R, D'Agati VD, Appel GB, et al. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy[J]. Kidney Int, 2015, 88(5):974-989. doi: 10.1038/ki.2015.252
|
[24] |
Ji SM, Xie KN, Cheng DR, et al. Long-term outcome of kidney transplantation from deceased donors with early graft dysfunction: a single-center analysis[J]. Indian J Appl Res, 2015, 5(5):761-764. http://worldwidejournals.in/ojs/index.php/ijar/article/download/9537/9622
|
[25] |
Shima Y, Nakanishi K, Kamei K, et al. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy[J]. Nephrol Dial Transplant, 2011, 26(1):163-169. doi: 10.1093/ndt/gfq387
|
[26] |
Sato K, Ishida H, Uchida K, et al. Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study[J]. Ther Apher Dial, 2013, 17(2):213-220. doi: 10.1111/tap.2013.17.issue-2
|
[27] |
Yuan Y, Wang Q, Ni Z, et al. Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study[J]. J Transl Med, 2015, 13:186. doi: 10.1186/s12967-015-0549-2
|
[28] |
Sofue T, Inui M, Hara T, et al. Association between post-transplantation immunoglobulin A deposition and reduced allograft function[J]. Transplant Proc, 2015, 47(2):332-336. doi: 10.1016/j.transproceed.2015.01.011
|
[29] |
Novak J, Rizk D, Takahashi K, et al. New insights into the pathogenesis of IgA nephropathy[J]. Kidney Dis, 2015, 1(1):8-18. doi: 10.1159/000382134
|